ERCC2 and hepatocellular carcinoma: However, decreased autophagy markers have been associated with more aggressive HCC phenotypes [115], and several tumor suppressors (e.g., XPD, PTPRO, TAK1 and Klotho) have also been reported to activate autophagy in HCC cells [116,117,118,119].